2 results
Approved WMOCompleted
The Purpose of the study is to investigate the clinical feasibility of the TW15 and TW22.
Approved WMOPending
To demonstrate in a phase III study that the addition of the monoclonal anti-T cell antibody alemtuzumab added to standard CHOP chemotherapy followed by autologous stam cell transplantation will increase the response, event-free survival,…